PSTX - Poseida Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Poseida Therapeutics's activity chart (see below) currently has 16 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 3.57% with an average time for these price targets to be met of 232 days.

Most recent stock forecast was given by from BTIG on 26-Nov-2024. First documented stock forecast 17-Aug-2020.

Best performing analysts who are covering PSTX - Poseida Therapeutics:

Edward Tenthoff Tyler Van Buren Jennifer Kim Justin Zelin Arthur He

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Justin Zelin (BTIG)

Buy Since 18-May-2021

$12

Please subscribe to see extended stock data

Arthur He (HC WAINWRIGHT)

Buy Since 04-Jan-2023

$-0.5 (-5.26%)

Please subscribe to see extended stock data

Edward Tenthoff (PIPER SANDLER)

Buy Since 18-May-2021

$10

$0.5 (5.26%)

$10

Please subscribe to see extended stock data

Jennifer Kim (CANTOR FITZGERALD)

Buy Since 07-Jan-2022

Please subscribe to see extended stock data

Tyler Van Buren (TD COWEN)

Buy

$30

$27.62 (1160.50%)

$30

Please subscribe to see extended stock data

Show more analysts

Load Price Targets and Ratings Chart

Please expand the browser size to see the chart

What is PSTX (Poseida Therapeutics) average time for price targets to be met?

On average it took 232 days on average for the stock forecasts to be realized with a an average price target met ratio 3.57

Which analyst has the current highest performing score on PSTX (Poseida Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on PSTX (Poseida Therapeutics) with a proven track record?

ARTHUR HE

Which analyst has the most public recommendations on PSTX (Poseida Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 3 price targets and 2 ratings on PSTX

Which analyst is the currently most bullish on PSTX (Poseida Therapeutics)?

Tyler Van Buren with highest potential upside - $27.62

Which analyst is the currently most reserved on PSTX (Poseida Therapeutics)?

Arthur He with lowest potential downside - -$0.5